📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis. (2015)

First Author: Garcia-Prats AJ

Attributed to: A phase III cluster randomised placebo-controlled trial to assess the efficacy of preventive therapy in child and adolescent contacts of MDR-TB funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.01404-15

PubMed Identifier: 26195507

Publication URI: http://europepmc.org/abstract/MED/26195507

Type: Journal Article/Review

Volume: 59

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 10

ISSN: 0066-4804